Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Hepatitis C Virus (HCV)”

1,487 trials

Showing 20 of 1,487 results

Post-approval studies (Phase 4)Study completedNCT03098121
What this trial is testing

Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection

Who this might be right for
Chronic Hepatitis C
Taoyuan General Hospital 40
Early research (Phase 1)Study completedNCT00630058
What this trial is testing

MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 20
Early research (Phase 1)Study completedNCT00623649
What this trial is testing

Safety,Tolerability and Pharmacokinetics of Multiple Ascending Doses of VCH 916 in Subjects With Chronic Hep C Infection

Who this might be right for
HCV Infection
Vertex Pharmaceuticals Incorporated 42
Early research (Phase 1)Study completedNCT04232514
What this trial is testing

Drug-drug Interaction Study Between HEC74647PA Capsule and HEC110114 Tablets in Healthy Subjects

Who this might be right for
Chronic Hepatitis C
Sunshine Lake Pharma Co., Ltd. 28
Early research (Phase 1)Study completedNCT01210404
What this trial is testing

Drug Interaction Study Of Filibuvir With Methadone Among Subjects On Chronic Methadone Maintenance

Who this might be right for
Chronic Hepatitis C
Pfizer 12
Large-scale testing (Phase 3)Study completedNCT00516321
What this trial is testing

Eltrombopag To Initiate And Maintain Interferon Antiviral Treatment To Subjects With Hepatitis C Related Liver Disease

Who this might be right for
Hepatitis C, Chronic
GlaxoSmithKline 687
Large-scale testing (Phase 3)Study completedNCT01492426
What this trial is testing

Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 605
Not applicableStudy completedNCT01442311
What this trial is testing

Directly Observed Hepatitis C Treatment in Methadone Clinics

Who this might be right for
Hepatitis CMedication Adherence
Albert Einstein College of Medicine 80
Testing effectiveness (Phase 2)Study completedNCT00722358
What this trial is testing

A Multiple Ascending Dose Study of BMS-650032 in HCV Infected Subjects

Who this might be right for
Chronic Hepatitis C
Bristol-Myers Squibb 15
Not applicableStudy completedNCT01509391
What this trial is testing

Keyhole Limpet Hemocyanin in Chronic Hepatitis C

Who this might be right for
Chronic Hepatitis CLiver Cirrhosis
Medical University of Graz 14
Not applicableEnded earlyNCT01200082
What this trial is testing

Sulfation of Bile Acids as a Biomarker for Hepatobiliary Diseases

Who this might be right for
Hepatobiliary Diseases
University of Nebraska 430
Large-scale testing (Phase 3)Study completedNCT02604017
What this trial is testing

Evaluate the Efficacy and Safety of ABT-493/ABT-530 in Subjects With Genotype 1 Infection

Who this might be right for
Chronic Hepatitis CHepatitis C VirusHCV
AbbVie 703
Testing effectiveness (Phase 2)Study completedNCT04075916
What this trial is testing

A Trial of Transplanting Hepatitis C Kidneys Into Hepatitis C-Negative Kidney Recipients

Who this might be right for
End Stage Renal Disease
University of Pennsylvania 201
Not applicableEnded earlyNCT02503735
What this trial is testing

Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)

Who this might be right for
Hepatitis CChronic Kidney Disease
Massachusetts General Hospital 14
Testing effectiveness (Phase 2)Study completedNCT00382798
What this trial is testing

Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin

Who this might be right for
Healthy VolunteersHepatitis C Virus
Pharmasset 75
Not applicableStudy completedNCT02439918
What this trial is testing

Epidemic History and Iatrogenic Transmission of Blood-borne Viruses in Mid-20th Century Kinshasa

Who this might be right for
HIVHTLV-1Hepatitis C, Chronic
Université de Sherbrooke 839
Not applicableStudy completedNCT02581020
What this trial is testing

The Durability of Response and Persistence of Resistance to AbbVie's 2 Direct-acting Antiviral Agent (2D) Therapy in Japanese Subjects

Who this might be right for
Hepatitis C Virus
AbbVie 344
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Post-approval studies (Phase 4)WithdrawnNCT03381859
What this trial is testing

Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
University of Maryland, Baltimore
Post-approval studies (Phase 4)Study completedNCT00474955
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 27
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation